In vivo studies revealed that metastatic tumour formation is decreased when CCL21 expression is knocked down in secondary lymphoid organs, since this diminishes both the chemotactic and antiapoptotic effects of CCR7-expressing tumour cells [11]. Here, CCL21 is linked to neoplasm.